{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:54:00Z","timestamp":1793084040571,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46990-0","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:04:42Z","timestamp":1776481482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cellular miRNA-31 and miRNA-125b as predictors of remission and major disease improvement in patients with early rheumatoid arthritis"],"prefix":"10.1038","volume":"16","author":[{"given":"Veronika","family":"Horv\u00e1thov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Vernerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Prajzlerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Krop\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Komarc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Filkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-7312","authenticated-orcid":false,"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"46990_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"46990_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102797","volume":"20","author":"N Petrovsk\u00e1","year":"2021","unstructured":"Petrovsk\u00e1, N., Prajzlerov\u00e1, K., Vencovsk\u00fd, J., \u0160enolt, L. & Filkov\u00e1, M. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis. Autoimmun. Rev. 20, 102797 (2021).","journal-title":"Autoimmun. Rev."},{"key":"46990_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101742","volume":"36","author":"K Bhamidipati","year":"2022","unstructured":"Bhamidipati, K. & Wei, K. Precision medicine in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 36, 101742 (2022).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"46990_CR4","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/cells10113017","volume":"10","author":"AL Mueller","year":"2021","unstructured":"Mueller, A. L. et al. Recent advances in understanding the pathogenesis of rheumatoid arthritis: New treatment strategies. Cells 10, 3017 (2021).","journal-title":"Cells"},{"key":"46990_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415479","volume":"23","author":"K Das","year":"2022","unstructured":"Das, K. & Rao, L. V. M. The role of microRNAs in inflammation. Int. J. Mol. Sci. 23, 15479 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"46990_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/cells11030452","volume":"11","author":"T Kmio\u0142ek","year":"2022","unstructured":"Kmio\u0142ek, T. & Paradowska-Gorycka, A. miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis. Cells 11, 452 (2022).","journal-title":"Cells"},{"key":"46990_CR7","doi-asserted-by":"publisher","first-page":"1087925","DOI":"10.3389\/fimmu.2023.1087925","volume":"14","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis. Front. Immunol. 14, 1087925 (2023).","journal-title":"Front. Immunol."},{"key":"46990_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13075-016-1023-0","volume":"18","author":"V Hruskova","year":"2016","unstructured":"Hruskova, V. et al. MicroRNA-125b: Association with disease activity and the treatment response of patients with early rheumatoid arthritis. Arthritis Res. Ther. 18, 124 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"46990_CR9","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"46990_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12519-019-00265-z","volume":"16","author":"ZD Fan","year":"2020","unstructured":"Fan, Z. D. et al. MicroRNA-125b regulates Th17\/Treg cell differentiation and is associated with juvenile idiopathic arthritis. World J. Pediatr. 16, 99\u2013110 (2020).","journal-title":"World J. Pediatr."},{"key":"46990_CR11","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1007\/s10528-023-10576-6","volume":"62","author":"P Xin","year":"2024","unstructured":"Xin, P., Tan, Z., Wang, Z., Chen, Y. & Zhuang, Y. Circular RNA hsa_circ_0000175 serves as a potential biomarker for rheumatoid arthritis via miR-31-5p\/GSDME axis. Biochem. Genet. 62, 2522\u20132539 (2024).","journal-title":"Biochem. Genet."},{"key":"46990_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/ijd.16962","volume":"63","author":"SF Saadawy","year":"2024","unstructured":"Saadawy, S. F., El-Ghareeb, M. I. & Talaat, A. MicroRNA-21 and microRNA-125b expression in skin tissue and serum as predictive biomarkers for psoriasis. Int. J. Dermatol. 63, 322\u2013329 (2024).","journal-title":"Int. J. Dermatol."},{"key":"46990_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11030421","volume":"11","author":"LV Gayosso-G\u00f3mez","year":"2021","unstructured":"Gayosso-G\u00f3mez, L. V. & Ortiz-Quintero, B. Circulating MicroRNAs in blood and other body fluids as biomarkers for diagnosis, prognosis, and therapy response in lung cancer. Diagnostics 11, 421 (2021).","journal-title":"Diagnostics"},{"key":"46990_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi, M. et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers. Cancer Cell 21, 121\u2013135 (2012).","journal-title":"Cancer Cell"},{"key":"46990_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02813","volume":"9","author":"M Bardua","year":"2018","unstructured":"Bardua, M. et al. MicroRNA-31 reduces the motility of proinflammatory T helper 1 lymphocytes. Front. Immunol. 9, 2813 (2018).","journal-title":"Front. Immunol."},{"key":"46990_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.omtn.2020.09.014","volume":"22","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Synovial mesenchymal stem cell-derived EV-packaged miR-31 downregulates histone demethylase KDM2A to prevent knee osteoarthritis. Mol. Ther. Nucleic Acids 22, 1078\u20131091 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"46990_CR17","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1073\/pnas.1200081109","volume":"109","author":"SW Kim","year":"2012","unstructured":"Kim, S. W. et al. MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. U. S. A. 109, 7865\u20137870 (2012).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"46990_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2017.05.007","volume":"488","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-\u03baB signaling pathway. Biochem. Biophys. Res. Commun. 488, 60\u201366 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"46990_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42601-3","volume":"9","author":"Z Rasheed","year":"2019","unstructured":"Rasheed, Z., Rasheed, N., Abdulmonem, W. A. & Khan, M. I. MicroRNA-125b-5p regulates IL-1\u03b2 induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-\u03baB signaling in human osteoarthritic chondrocytes. Sci. Rep. 9, 6882 (2019).","journal-title":"Sci. Rep."},{"key":"46990_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/acel.12294","volume":"14","author":"NL Cheng","year":"2015","unstructured":"Cheng, N. L. et al. MicroRNA-125b modulates inflammatory chemokine CCL4 expression in immune cells and its reduction causes CCL4 increase with age. Aging Cell 14, 200\u2013208 (2015).","journal-title":"Aging Cell"},{"key":"46990_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbrc.2017.07.135","volume":"491","author":"W Diao","year":"2017","unstructured":"Diao, W. et al. MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7\u2013H4. Biochem. Biophys. Res. Commun. 491, 912\u2013918 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"46990_CR22","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4161\/cc.25251","volume":"12","author":"MY Murray","year":"2013","unstructured":"Murray, M. Y., Rushworth, S. A., Zaitseva, L., Bowles, K. M. & Macewan, D. J. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression. Cell Cycle 12, 2144\u20132153 (2013).","journal-title":"Cell Cycle"},{"key":"46990_CR23","first-page":"317","volume":"26","author":"S Herman","year":"2008","unstructured":"Herman, S., Zurgil, N., Langevitz, P., Ehrenfeld, M. & Deutsch, M. Methotrexate selectively modulates TH1\/TH2 balance in active rheumatoid arthritis patients. Clin. Exp. Rheumatol. 26, 317\u2013323 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"46990_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1128\/CVI.00061-11","volume":"18","author":"S Herman","year":"2011","unstructured":"Herman, S. et al. Distinct effects of anti-tumor necrosis factor combined therapy on TH1\/TH2 balance in rheumatoid arthritis patients. Clin. Vaccine Immunol. 18, 1077\u20131082 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"46990_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-020-00827-8","volume":"42","author":"A Shimba","year":"2020","unstructured":"Shimba, A. & Ikuta, K. Control of immunity by glucocorticoids in health and disease. Semin. Immunopathol. 42, 669\u2013680 (2020).","journal-title":"Semin. Immunopathol."},{"key":"46990_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein, B. N. & Aune, T. M. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat. Rev. Rheumatol. 16, 145\u2013154 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"46990_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.33549\/physiolres.933615","volume":"66","author":"L Borska","year":"2017","unstructured":"Borska, L. et al. Roles of miR-31 and endothelin-1 in psoriasis vulgaris: Pathophysiological functions and potential biomarkers. Physiol. Res. 66, 987\u2013992 (2017).","journal-title":"Physiol. Res."},{"key":"46990_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oraloncology.2015.11.017","volume":"53","author":"KF Hung","year":"2016","unstructured":"Hung, K. F. et al. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncol. 53, 42\u201347 (2016).","journal-title":"Oral Oncol."},{"key":"46990_CR29","doi-asserted-by":"publisher","first-page":"87837","DOI":"10.18632\/oncotarget.21237","volume":"8","author":"H Jacob","year":"2017","unstructured":"Jacob, H. et al. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. Oncotarget 8, 87837\u201387847 (2017).","journal-title":"Oncotarget"},{"key":"46990_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/bjc.2017.256","volume":"117","author":"D Piatopoulou","year":"2017","unstructured":"Piatopoulou, D. et al. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. Br. J. Cancer 117, 801\u2013812 (2017).","journal-title":"Br. J. Cancer"},{"key":"46990_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36999-0","volume":"13","author":"\u00c5K Hedman","year":"2023","unstructured":"Hedman, \u00c5. K. et al. Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. Sci. Rep. 13, 10058 (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46990-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46990-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46990-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:53:24Z","timestamp":1781049204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46990-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46990"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46990-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the local ethics committee (no. 3294\/2012) of the Institute of Rheumatology in Prague, Czech Republic. The study was approved by the local ethics committee of the Institute of Rheumatology in Prague, Czech Republic, and is registered under ethical approval number 3294\/2012. Written informed consent was obtained from all participants. All experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17962"}}